<DOC>
	<DOCNO>NCT00820807</DOCNO>
	<brief_summary>This study critically evaluate effect novel dietary fiber administer subject high risk develop diabetes determine intervention improve insulin sensitivity compare control product administration , thus , decrease risk develop diabetes . The hypothesis consume novel fiber twice day 12 week significantly decrease fast plasma glucose , insulin glycosylated hemoglobin value pre-diabetic subject ( i.e . subject fast plasma glucose level 95-140 mg/dl screen ) compare consumption control product .</brief_summary>
	<brief_title>Effects Novel Fiber Glucose Homeostasis Individuals Risk Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Male female racial/ethnic group ; able read , comprehend , write English sufficient level complete studyrelated material Age : &gt; 30 &lt; 65 year randomization trial BMI : 2535 kg/m2 randomization trial Fasting blood glucose : 95140 mg/dl ( glucose 9599mg/dl , must history gestational diabetes first degree relative ( parent sibling ) history diabetes ; glucose 100125 mg/dl , enrol primary target recruitment ; glucose 126140 mg/dl ( asymptomatic diabetes ) , must prior diagnosis diabetes must prior treatment/pharmacotherapy diabetes ) Good general health evidence medical history Blood chemistry urinalysis result within normal range within acceptable range determine physician site and/or consultation Medical Monitor Available willing participate study 15 week Willing follow weightmaintaining Lifestyle diet throughout 12 week trial , maintain physical activity pattern baseline level throughout study period , add new exercise routine , dietary supplement , vitamin unusual food product Willing consume two 16 oz beverage every day meals 12 week able transport test article Presence condition Investigator believe would interfere subject 's ability provide inform consent , comply study instruction , might confound interpretation study result put subject undue risk Food allergy sensitivity ingredient study product ( e.g . Gluten sensitivity , celiac disease ) Participation another clinical trial might interfere trial exposure investigational agent within 30 day prior first visit History diabetes ( subject prior history gestational diabetes may enrol pharmacologic treatment diabetes since pregnancy ) Treatment diabetes relate condition ( e.g. , polycystic ovary syndrome ) metformin , oral agent , insulin injection use diabetes management Uncontrolled hypertension ( i.e. , systolic blood pressure &gt; 160 mm Hg , diastolic blood pressure &gt; 95 mmHg base average 3 reading sit ) Fasting serum triglyceride value &gt; 200 mg/dl ( since change triglyceride value affect glucose homeostasis ) Untreated hypothyroidism TSH &gt; 1.5 time upper limit normal test laboratory repeat value also exceed limit Recent history weight loss ( &gt; 4 kg past 3 month ) significant variation weight ( &gt; 4 kg past 3 month , example , due medical condition pregnancy , hormonal therapy ) Use medication herbal remedy weight loss ( e.g. , sibutramine , orlistat , amphetamine , phentermine , huang ) use substance within past 3 month Current recent history ( past 12 month ) drug , alcohol chemical abuse . Alcohol abuse define &gt; 14 drink per week ( 1 drink = 12 oz beer , 5 oz wine , 1.5 oz hard liquor ) Pregnant , breastfeed female childbearing potential unwilling commit use medically approve form contraception throughout study period .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>dietary fiber</keyword>
	<keyword>fiber</keyword>
	<keyword>insulin sensitivity</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>glucose metabolism</keyword>
</DOC>